Endogenous aspartoacylase expression is responsive to glutamatergic activity in vitro and in vivo

GLIA

Volumn 59, Issue 10, 2011, Pages 1435-1446

  Francis, Jeremy S ^a   Strande, Louise ^a   Pu, Amy ^a   Leone, Paola ^a  

^a UMDNJ School of Osteopathic Medicine   (United States)

Author keywords

Aspartoacylase; Development; Glutamate oligodendrocyte; Transcription

Indexed keywords

ASPARTOACYLASE; GLUTAMIC ACID; VESICULAR GLUTAMATE TRANSPORTER 1;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL POPULATION; CONTROLLED STUDY; DEVELOPMENTAL STAGE; GENE EXPRESSION; GENETIC TRANSCRIPTION; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; NULL ALLELE; OLIGODENDROGLIA; POSTNATAL DEVELOPMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SYNAPTIC TRANSMISSION; TRANSCRIPTION REGULATION; UPREGULATION;

AGE FACTORS; AMIDOHYDROLASES; ANIMALS; ANIMALS, NEWBORN; BRAIN; CELL LINE, TRANSFORMED; CELLS, CULTURED; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; GLUTAMIC ACID; GREEN FLUORESCENT PROTEINS; HUMANS; MICE; O ANTIGENS; OLIGODENDROGLIA; RATS; TRANSFECTION; VESICULAR GLUTAMATE TRANSPORT PROTEIN 1;

EID: 79960729662     PISSN: 08941491     EISSN: 10981136     Source Type: Journal    
DOI: 10.1002/glia.21187     Document Type: Article

References (43)

1. Barres BA, Raff MC. 1994. Control of oligodendrocyte number in the developing rat optic nerve. Neuron 12: 935-942.
2. Baslow MH, Suckow RF, Sapirstein V, Hungund BL. 1999. Expression of aspartoacylase activity in cultured rat macroglial cells is limited to oligodendrocytes. J Mol Neurosci 13: 47-53.
3. Baudry M, Lynch G. 1979. Regulation of glutamate receptors by cations. Nature 282: 748-750.
4. Bellocchio EE, Reimer RJ, Fremeau RTJr, Edwards RH. 2000. Uptake of glutamate into synaptic vesicles by an inorganic phosphate transporter. Science 289: 957-960.
5. Bhakoo KK, Craig TJ, Styles P. 2001. Developmental and regional distribution of aspartoacylase in rat brain tissue. J Neurochem 79: 211-220.
6. Bergles DE, Roberts JD, Somogyi P, Jahr CE. 2000. Glutamatergic synapses on oligodendrocyte precursor cells in the hippocampus. Nature 405: 187-191.
7. Bhat RV, Axt KJ, Fosnaugh JS, Smith KJ, Johnson KA, Hill DE, Kinzler KW, Baraban JM. 1996. Expression of the APC tumor suppressor protein in oligodendroglia. Glia 17: 169-174.
8. Bjartmar C, Battistuta J, Terada N, Dupree E, Trapp BD. 2002. N-acetylaspartate is an axon-specific marker of mature white matter in vivo: A biochemical and immunohistochemical study on the rat optic nerve. Ann Neurol 51: 51-58.
9. Chakranorty G, Mekala P, Yahya D, Wu G, Ledeen RW. 2001. Intraneuronal N-acetylaspartate supplies acetyl groups for myelin lipid synthesis: Evidence for myelinassociated aspartoacylase. J Neurochem 78: 736-745.
10. Clark JB. 1998. N-acetyl aspartate: A marker for neuronal loss or mitochondrial dysfunction. Dev Neurosci 20: 271-276.
11. D'Adamo AFJr, Gidez LI, Yatsu FM. 1968. Acetyl transport mechanisms. Involvement of N-acetyl aspartic acid in de novo fatty acid biosynthesis in the developing rat brain. Exp Brain Res 5: 267-273.
12. De Stefano N, Matthews PM, Arnold DL. 1995. Reversible decreases in N-acetylaspartate after acute brain injury. Mag Reson Med 34: 721-727.
13. Francis JS, Olariu A, McPhee SW, Leone P. 2006. Novel role for aspartoacylase in regulation of BDNF and timing of postnatal oligodendrogenesis. J Neurosci Res 84: 151-169.
14. Francis JS, Olariu A, Kobayashi E, Leone P. 2007. GFP-transgenic Lewis rats as a cell source for oligodendrocyte replacement. Exp Neurol 205: 177-189.
15. Gault LM, Siegel RE. 1997. Expression of the GABAA receptor delta subunit is selectively modulated by depolarization in cultured rat cerebellar neurons. J Neurosci 17: 2391-2399.
16. Hanaya R, Kiura Y, Kurisu K, Sakai N, Serikawa T, Sasa M. 2008. N-acetyl-L-aspartate activates hippocampal CA3 neurons in rodent slice preparations. Brain Res Bull 75: 663-667.
17. Juge N, Gray JA, Omote H, Miyaji T, Inoue T, Hara C, Uneyama H, Edwards RH, Nicoll RA, Moriyama Y. 2010. Metabolic control of vesicular glutamate transport and release. Neuron 68: 99-112.
18. Karadottir R, Cavelier P, Bergersen LH, Attwell D. 2005. NMDA receptors are expressed in oligodendrocytes and activated in ischemia. Nature 438: 1162-1166.
19. Kaul R, Gao GP, Balamurugan K, Matalon R. 1993. Cloning of the human aspartoacylase cDNA and a common missense mutation in Canavan disease. Nat Genet 5: 118-123.
20. Kaul R, Balamurugan B, Gao GP, Matalon R. 1994. Canavan disease: Genomic organization and localization of human ASPA to 17p13-ter and conservation of the ASPA gene during evolution. Genomics 21: 364-370.
21. Kirmani BF, Jacobowitz DM, Namboodiri MA. 2003. Developmental increase of aspartoacylase in oligodendrocytes parallels CNS myelination. Brain Res Dev Brain Res 140: 105-115.
22. Kolodziejczyk K, Hamilton NB, Wade A, Karadottir R, Attwell D. 2009. The effect of N-acetyl-aspartyl-glutamate and N-acetyl-aspartate on white matter oligodendrocytes. Brain 132: 1496-1508.
23. Kukley M, Capetillo-Zarate E, Dietrich D. 2007. Vesicular glutamate release from axons in white matter. Nat Neurosci 10: 311-320.
24. Le Coq J, An HJ, Lebrilla C, Viola RE. 2006. Characterization of human aspartoacylase: The brain enzyme responsible for Canavan disease Biochemistry 45: 5878-5884.
25. Madhavarao CN, Moffett JR, Moore RA, Viola RE, Namboodiri MA, Jacobowitz DM. 2004. Immunohistochemical localization of aspartoacylase in the rat central nervous system. J Comp Neurol 472: 318-329.
26. Madhavarao CN, Arun P, Moffett JR, Szucs S, Surendran S, Matalon R, Garbern J, Hristova D, Johnson A, Jiang W, Namboodiri MA. 2005. Defective N-acetylaspartate catabolism reduces brain acetate levels and myelin lipid synthesis in Canavan's disease. Proc Natl Acad Sci USA 102: 5221-5226.
27. Mattan NS, Ghiani CA, Lloyd M, Matalon R, Bok D, Casaccia P, de Vellis J. 2010. Aspartoacylase deficiency affects early postnatal development of oligodendrocytes and myelination. Neurobiol Dis 40: 432-443.
28. Micu I, Jiang Q, Coderre E, Risdale A, Zhang L, Woulfe J, Yin X, Trapp BD, McRory JE, Rehak R, Zamponi GW, Wang W, Stys PK. 2006. NMDA receptors mediate calcium accumulation in myelin during chemical ischemia. Nature 439: 988-992.
29. Paxinos G, Ashwell KS, Tork I, editors. 1994. Atlas of the developing rat nervous system, Academic Press.
30. Patel TB, Clark JB. 1979. Synthesis of N-acetyl-L-aspartate by rat brain mitochondria and its involvement in mitochondrial/cytosolic carbon transport. Biochem J 184: 539-546.
31. Petroff OAC, Errante LD, Rothman DL, Kim JH, Spencer DD. 2002. Neuronal and glial metabolite content of the epileptogenic human hippocampus. Ann Neurol 52: 635-642.
32. Surendran S, Rady PL, Michals-Matalon K, Quast MJ, Rassin DK, Campbell GA, Ezell EL, Wei J, Tyring SK, Szucs S, Matalon R. 2003. Expression of glutamate transporter, GABRA6, serine proteinase inhibitor 2 and low levels of glutamate and GABA in the brain of knock-out mouse for Canavan disease. Brain Res Bull 61: 427-435.
33. Traka M, Wollmann RL, Cerda SR, Dugas J, Barres BA, Popko B. 2008. Nur7 is a nonsense mutation in the mouse aspartoacylase gene that causes spongy degeneration of the CNS. J Neurosci 28: 11537-11549.
34. Truckenmiller ME, Namboodiri MA, Brownstein MJ, Neale JH. 1985. N-acetylation of L-aspartate in the nervous system. J Neurochem 45: 1658-1652.
35. Wang J, Leone P, Wu G, Francis JS, Li H, Jain MR, Serikawa T, Ledeen RW. 2009. Myelin lipid abnormalities in the aspartoacylase-deficient tremor rat. Neurochem Res 34: 138-148.
36. West MJ, Slomianka L, Gundersen HJ. 1991. Unbiased stereological estimation of the total number of neurons in the subdivisions of the rat hippocampus using the optical fractionator. Anat Res 231: 482-497.
37. Wilson NR, Kang J, Hueske EV, Leung T, Varoqui H, Murnick JG, Erickson JD, Liu G. 2005. Presynaptic regulation of quantal size by the vesicular glutamate transporter VGLUT1. J Neurosci 25: 6221-6234.
38. Wojcik SM, Rhee JS, Herzog E, Sigler A, Jahn R, Takamori S, Brose N, Rosenmund C. 2004. An essential role for vesicular glutamate transporter 1 (VGLUT1) in postnatal development and control of quantal size. Proc Natl Acad Sci USA 101: 7158-7163.
39. Takayasu Y, Ino M, Ozawa S. 2004. Roles of glutamate transporters in shaping excitatory synaptic currents in cerebellar Purkinje cells. Eur J Neurosci 19: 1285-1295.
40. Xiao X, Li J, Samulski RJ. 1998. Production of high-titer recombinant adeno-associated virus vectors in the absence of helper adenovirus. J Virol 72: 2224-2232.
41. Yan HD, Ishihara K, Serikawa T, Sasa M. 2003. Activation by N-acetyl-L-aspartate of acutely dissociated hippocampal neurons in rats via metabotropic glutamate receptors. Epilepsia 44: 1153-1159.
42. Yu AC, Schousboe A, Hertz L. 1982. Metabolic fate of 14C-labeled glutamate in astrocytes in primary cultures. J Neurochem 39: 954-960.
43. Ziskin JL, Nishiyama A, Rubio M, Fukaya M, Bergles DE. 2007. Vesicular release of glutamate from unmyelinated axons in white matter. Nat Neurosci 10: 321-330.